Navigation Links
ReBuilder Medical Technologies, Inc. Increases Staffing by 30% in Three Weeks Due to Increase in Demand for All ReBuilder Medical Products
Date:10/2/2007

, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.


'/>"/>
SOURCE ReBuilder Medical Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Check if your “Favourite medical web-site” is indulging in Quackey
2. Teens turning to Internet for medical queries
3. Robots craft medical history
4. NBE to conduct test for medical students from abroad
5. Air pollution combined with greater medical needs
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. Children! Protecting them from medical mistakes
8. More information sought by patients on medical errors
9. SARS necessitates medical masks
10. Meditation Works Medically
11. Sleep Disorders Could Indicate Other Medical Problems

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...5/PRNewswire/-SentinelleMedicalInc.,aleadingmanufa...areandCalgaryScientificInc.,aleadingproviderofsoft...ofAegis(TM)Breast4DAdvancedVisualizationsoftware. ...ootprintWebclientbasedmedicalimagingofferinginthem...forzero-footprintaccess-requiringnosoftwaredownloa...
(Date:11/25/2009)...ewswire/--TheBayAreaAirQualityManagementDistrictis...Air Alert forThursday,November26,2009whichban...el,bothindoorsandoutdoors. ,, "Cold,stillweathe...JackBroadbent,executiveofficeroftheAirDistrict."We...neighborsandfellowcommunitymembersthisThanksgiving...
(Date:11/25/2009)...essure? This simple question has been the focus o...ated gene Modulates High Blood Pressure in Mice & ...imple question has been the focus of intense resea...first time established a link between a novel gene...ress in mice as well as humans. The studies were d...
(Date:11/25/2009)...ological symptoms, study finds , , WEDN...de effects are among the potential problems faced ...re treated with cisplatin-based chemotherapy, a ne...orwegian men treated for unilateral testicular can...w-up survey conducted from 1998 to 2002. , The ...
(Date:11/25/2009)...vaccine carried into the body on a carefully engin...ccessfully eliminate tumors in mammals, scientists...ional Medicine . , The new approach, pioneered b...sity, uses plastic disks impregnated with tumor-sp...program the mammalian immune system to attack tumo...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
.... scientists discover an effective method of vacci...ium Yersinia pestis//, with the details of their s...ture Immunology. Egil Lien and his colleagues a...fatty sugars in the development of an effective va...
... Waters’ missionary work to spread the Gospel to f...ecades, but it left his head pounding.// Begi...t eventually forced him to return home. Medi... caused facial throbbing, until he came to the Eug...
... blame yourself, if your taste buds get tickled at...re mention! A recent investigation into the reaso...arian food has shown that such tendencies are gene...be in the pink of health. To understand such incli...
...rotein helps lower total cholesterol, low-density ...ghtly raises high-density lipid “good” cholesterol...ed in the Sept. 1, 2006 issue of The American Jour...or the prevention and treatment of high blood chol...
...ent study reveals that short sessions (a few minut... same results as moderate exercises done for hours...inesiology at McMaster University and his team con...g finding from our study was the remarkably simila...
...to - Those Canadians who live in far-flung areas r...to the city-dwellers, primarily due to an increase...idental injury, as stated by a report released by ...nt in the god-forsaken areas of rural Canada, in s...
Other Medicine News:Health News:Different Techniques Can Help Ease Chronic Pain, Return Patients’ Smile 2Health News:Different Techniques Can Help Ease Chronic Pain, Return Patients’ Smile 3Health News:Rural Canadians, Take Care Of Your Health 2
(Date:11/25/2009).../PRNewswire-FirstCall/--HeskaCorporation(HSKA);("H...ecialtyproductstotheveterinaryindustry,announcedto...supplyofbloodgasproductsandaffiliatedconsumablesfo...com.com/cgi-bin/prnh/20000622/HESKALOGO ) ,, "H...ieldofadvancedpoint-of-carediagnostics,"commentedM...
(Date:11/25/2009)...wswire/--BioTrendsResearchGroup,Inc.releasedWave1o...tinamulti-phasesyndicatedmarketresearchprojecttrac...productlaunchthroughthefirstsixmonthsofavailabilit...onfrom75uniqueDermatologistsandqualitativeinformat...elara,obstaclestouse,typicalpatienttypes,productpe...
(Date:11/25/2009)....25/PRNewswire/--RegadoBiosciences,aprivatelyheldc...swithactivecontrolagents,announcedthatDavidMazzo,P...ay21stAnnualHealthCareConferenceattheNewYorkPalace...enat1:10pm(EST)onTuesday,December1andwillincludean...ddevelopmentprogram,theanticoagulantsystem,REG1.Th...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Herley Reports Fourth Quarter and Year End Results 59611 1Herley Reports Fourth Quarter and Year End Results 59611 2Herley Reports Fourth Quarter and Year End Results 59611 3Herley Reports Fourth Quarter and Year End Results 59611 4Herley Reports Fourth Quarter and Year End Results 59611 5Herley Reports Fourth Quarter and Year End Results 59611 6Herley Reports Fourth Quarter and Year End Results 59611 7Herley Reports Fourth Quarter and Year End Results 59611 8Herley Reports Fourth Quarter and Year End Results 59611 9Herley Reports Fourth Quarter and Year End Results 59611 10Herley Reports Fourth Quarter and Year End Results 59611 11Herley Reports Fourth Quarter and Year End Results 59611 12Patent challenges reduce pharmaceutical innovation and productivity researchers suggest 59608 1Patent challenges reduce pharmaceutical innovation and productivity researchers suggest 59608 2Patent challenges reduce pharmaceutical innovation and productivity researchers suggest 59608 3Scientists use math modeling to predict unknown biological mechanism of regulation 14500 1Scientists use math modeling to predict unknown biological mechanism of regulation 14500 2
...ical data for potential combination,therapies and ...r,ITMN-191 exposure, BARCELONA, Spain, April 11, 2...unced today the presentation of findings from,thre... inhibitor,ITMN-191, alone or in combination with ... European Association for the Study of the,Liver i...
...IRE)--Apr 11, 2007 - New data,supporting the clini... most advanced investigational oral protease inhib... infection, will be presented,at the 42nd Annual M...f the Liver (EASL) in Barcelona this week. In tota...accepted for presentation,at the EASL conference, ...
Other Medicine Technology:InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting 2InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting 3InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting 4Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 2Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 3Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 4Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 5Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 6
LD Lactate –> Pyruvate
Rheumatoid Factor Latex Test (RF)
IgG (sample dilution, 1-shot only) (Liquid)
CRP (Complete Kit with Disposible Cards)
Medicine Products: